Search

Search Constraints

You searched for: Author/Creator Lythgoe, Mark

Search Results

1. Non-invasive imaging of disrupted protein homeostasis induced by proteasome inhibitor treatment using chemical exchange saturation transfer MRI. Issue 1 (December 2018)

2. Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies. (December 2017)

4. O4‐02‐04: BRAIN TEXTURE ANALYSIS AS A BIOMARKER FOR TAUOPATHY IN A TRANSGENIC MOUSE MODEL OF ALZHEIMER'S. (1st July 2014)

5. Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors. Issue 6 (12th December 2019)

6. Noninvasive quantification of oxygen saturation in the portal and hepatic veins in healthy mice and those with colorectal liver metastases using QSM MRI. Issue 4 (19th November 2018)

7. O4‐02‐06: AN IMAGING STRATEGY TO CHARACTERISE TAU PATHOLOGY IN VIVO IN A MODEL OF ALZHEIMER'S DISEASE USING MULTI‐PARAMETRIC MRI. (1st July 2014)

8. 805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours. (10th December 2020)

9. 805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours. (9th November 2020)